NRF2 ACTIVATOR FOR THE TREATMENT OF ACUTE LUNG INJURY, ACUTE RESPIRATORY DISTRESS SYNDROME AND MULTIPLE ORGAN DYSFUNCTION SYNDROME

摘要

The present invention relates to the use of an NRF2 activator to treat respiratory diseases. In particular, the present invention relates to the treatment of respiratory diseases, in a mammal, in which related organ failure accompanied by accumulation of alveolar fluid, cough, wheezing, dyspnea, hyperpnea, hypoxemia and pulmonary inflammation has occurred.